natgillin/translations-raw huggingface dataset:
The active substance in the product placed on the market can be of equal or different purity if it has been proven technically equivalent with the evaluated active substance.
Kadar je bil izdelek obdelan z enim ali več biocidnimi proizvodi, ki vsebujejo 4,5-dikloro-2-oktil-2H-izotiazol-3-on, ali take proizvode namensko vsebuje in kadar je to potrebno zaradi možnosti stika s kožo ali sprostitve 4,5-dikloro-2-oktil-2H-izotiazol-3-ona v normalnih pogojih uporabe, oseba, pristojna za dajanje izdelka na trg, zagotovi, da so na oznaki navedene informacije o tveganju za senzibilizacijo kože in informacije iz drugega pododstavka člena 58(3) Uredbe (EU) št. 528/2012.
For the implementation of the common principles of Annex VI to Regulation (EU) No 528/2012, the content and conclusions of assessment reports are available on the Commission website: http://ec.europa.eu/comm/environment/biocides/index.htm
Čistost, navedena v tem stolpcu, je bila minimalna stopnja čistosti aktivne snovi, uporabljene za oceno v skladu s členom 8 Uredbe (EU) št. 528/2012.
Regulation (EC) No 470/2009 of the European Parliament and of the Council of 6 May 2009 laying down Community procedures for the establishment of residue limits of pharmacologically active substances in foodstuffs of animal origin, repealing Council Regulation (EEC) No 2377/90 and amending Directive 2001/82/EC of the European Parliament and of the Council and Regulation (EC) No 726/2004 of the European Parliament and of the Council (OJ L 152, 16.6.2009, p. 11).
Čistost aktivne snovi v proizvodu, danem na trg, je lahko enaka ali drugačna, če je dokazano tehnično enakovredna aktivni snovi iz ocene.
Regulation (EC) No 396/2005 of the European Parliament and of the Council of 23 February 2005 on maximum residue levels of pesticides in or on food and feed of plant and animal origin and amending Council Directive 91/414/EEC (OJ L 70, 16.3.2005, p. 1).
Za izvajanje splošnih načel iz Priloge VI k Uredbi (EU) št. 528/2012 so vsebina in sklepne ugotovitve poročil o oceni na voljo na naslednjem spletišču Komisije: http://ec.europa.eu/comm/environment/biocides/index.htm.
Commission Implementing Regulation (EU) No 438/2014
Izvedbena uredba Komisije (EU) št. 438/2014
approving cyproconazole as an existing active substance for use in biocidal products for product-type 8
o odobritvi ciprokonazola kot obstoječe aktivne snovi za uporabo v biocidnih proizvodih 8. vrste proizvodov
Having regard to Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012 concerning the making available on the market and use of biocidal products [1], and in particular the third subparagraph of Article 89(1) thereof,
ob upoštevanju Uredbe (EU) št. 528/2012 Evropskega parlamenta in Sveta z dne 22. maja 2012 o dostopnosti na trgu in uporabi biocidnih proizvodov [1] ter zlasti tretjega pododstavka člena 89(1) Uredbe,
Commission Regulation (EC) No 1451/2007 [2] establishes a list of active substances to be assessed, with a view to their possible inclusion in Annex I, IA or IB to Directive 98/8/EC of the European Parliament and of the Council [3].
Uredba Komisije (ES) št. 1451/2007 [2] določa seznam aktivnih snovi, ki jih je treba oceniti z namenom njihove možne vključitve v Prilogo I, IA ali IB k Direktivi 98/8/ES Evropskega parlamenta in Sveta [3].
That list includes cyproconazole.
Navedeni seznam vključuje ciprokonazol.
Cyproconazole has been evaluated in accordance with Article 11(2) of Directive 98/8/EC for use in product-type 8, wood preservatives, as defined in Annex V to that Directive, which corresponds to product-type 8 as defined in Annex V to Regulation (EU) No 528/2012.
V skladu s členom 11(2) Direktive 98/8/ES je bila opravljena ocena ciprokonazola glede uporabe v 8. vrsti proizvodov (pripravki za zaščito lesa), kot je opredeljena v Prilogi V k navedeni direktivi, ki ustreza 8. vrsti proizvodov, kot je opredeljena v Prilogi V k Uredbi (EU) št. 528/2012.
Ireland was designated as Rapporteur Member State and submitted the competent authority report, together with a recommendation, to the Commission on 30 May 2012 in accordance with Article 14(4) and (6) of Regulation (EC) No 1451/2007.
Irska, ki je bila imenovana za državo članico poročevalko, je 30. maja 2012 v skladu s členom 14(4) in (6) Uredbe (ES) št. 1451/2007 Komisiji poslala poročilo pristojnega organa in priporočilo.
In accordance with Article 15(4) of Regulation (EC) No 1451/2007, the findings of the review were incorporated in an assessment report reviewed within the Standing Committee on Biocidal Products on 13 March 2014.
V skladu s členom 15(4) Uredbe (ES) št. 1451/2007 so bile ugotovitve pregleda 13. marca 2014 v Stalnem odboru za biocidne pripravke vključene v poročilo o oceni.
According to that assessment report, biocidal products used for product-type 8 and containing cyproconazole may be expected to satisfy the requirements laid down in Article 5 of Directive 98/8/EC provided that certain specifications and conditions relating to its use are satisfied.
V skladu s poročilom o oceni je razvidno, da je za biocidne pripravke, ki se uporabljajo za 8. vrsto proizvodov in vsebujejo ciprokonazol, mogoče pričakovati, da izpolnjujejo zahteve iz člena 5 Direktive 98/8/ES, če so izpolnjene določene specifikacije in pogoji glede njihove uporabe.
It is therefore appropriate to approve cyproconazole for use in biocidal products for product-type 8 subject to compliance with such specifications and conditions.
Zato je primerno odobriti ciprokonazol za uporabo v biocidnih pripravkih 8. vrste proizvodov, pod pogojem, da je to v skladu s takšnimi specifikacijami in pogoji.
Since the evaluation did not address nanomaterials, the approval should not cover such materials pursuant to Article 4(4) of Regulation (EU) No 528/2012.
Ker v oceno niso bili vključeni nanomateriali, jih odobritev v skladu s členom 4(4) Uredbe (EU) št. 528/2012 ne bi smela zajemati.
The report concludes that cyproconazole meets the criteria for being classified as toxic for reproduction category 1B in accordance with Regulation (EC) No 1272/2008 of the European Parliament and of the Council [4], and for being very persistent (vP) and toxic (T) according to Annex XIII to Regulation (EC) No 1907/2006.
V poročilu je ugotovljeno, da ciprokonazol izpolnjuje kriterije za uvrstitev med snovi, strupene za razmnoževanje iz skupine 1B, v skladu z Uredbo (ES) št. 1272/2008 Evropskega parlamenta in Sveta [4], ter kot zelo obstojna snov (vP) in strupena snov (T) v skladu s Prilogo XIII k Uredbi (ES) št. 1907/2006.
Notwithstanding the fact that the existing harmonised classification of cyproconazole should be revised pursuant to Article 37 of Regulation (EC) No 1272/2008, those intrinsic properties should be taken into account for the purpose of determining the period of approval.
Kljub dejstvu, da bi bilo treba obstoječo usklajeno razvrščanje ciprokonazola pregledati v skladu s členom 37 Uredbe (ES) št. 1272/2008, bi bilo treba navedene bistvene lastnosti upoštevati za namene določanja obdobja za odobritev.
Since the conditions of the first subparagraph of Article 90(2) of Regulation (EU) No 528/2012 are not met, the current practice under Directive 98/8/EC should be followed.
Ker pogoji iz prvega pododstavka člena 90(2) Uredbe (EU) št. 528/2012 niso izpolnjeni, bi bilo treba upoštevati tekočo prakso iz Direktive 98/8/ES.
The period of approval should therefore be five years.
Obdobje odobritve bi zato moralo biti pet let.
However, for the purpose of authorising products in accordance with Article 23 of Regulation (EU) No 528/2012, cyproconazole shall be considered as a candidate for substitution pursuant to Article 10(1)(a) and (d) of that Regulation.
Vendar se za namene odobritve proizvodov v skladu s členom 23 Uredbe (EU) št. 528/2012 ciprokonazol obravnava kot snov za zamenjavo v skladu s členom 10(1)(a) in (d) navedene uredbe.
A reasonable period should be allowed to elapse before an active substance is approved, in order to permit interested parties to take the preparatory measures necessary to meet the new requirements laid down.
Pred odobritvijo aktivne snovi bi bilo treba zagotoviti razumen rok, ki bo omogočil deležnikom, da sprejmejo vse potrebne pripravljalne ukrepe za izpolnitev novih zahtev.
Cyproconazole shall be approved as an active substance for use in biocidal products for product-type 8, subject to the specifications and conditions set out in the Annex.
Ciprokonazol se odobri kot aktivna snov za uporabo v biocidnih proizvodih 8. vrste proizvodov, pri čemer se upoštevajo specifikacije in pogoji iz Priloge.
Commission Regulation (EC) No 1451/2007 of 4 December 2007 on the second phase of the 10-year work programme referred to in Article 16(2) of Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market (OJ L 325, 11.12.2007, p. 3).
Uredba Komisije (ES) št. 1451/2007 z dne 4. decembra 2007 o drugi fazi desetletnega delovnega programa iz člena 16(2) Direktive 98/8/ES Evropskega parlamenta in Sveta o dajanju biocidnih pripravkov v promet (UL L 325, 11.12.2007, str. 3).
Directive 98/8/EC of the European Parliament and of the Council of 16 February 1998 concerning the placing of biocidal products on the market (OJ L 123, 24.4.1998, p. 1).
Direktiva 98/8/ES Evropskega parlamenta in Sveta z dne 16. februarja 1998 o dajanju biocidnih pripravkov v promet (UL L 123, 24.4.1998, str. 1).
Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, amending and repealing Directives 67/548/EEC and 1999/45/EC, and amending Regulation (EC) No 1907/2006 (OJ L 353, 31.12.2008, p. 1).
Uredba (ES) št. 1272/2008 Evropskega parlamenta in Sveta z dne 16. decembra 2008 o razvrščanju, označevanju in pakiranju snovi ter zmesi, o spremembi in razveljavitvi direktiv 67/548/EGS in 1999/45/ES ter spremembi Uredbe (ES) št. 1907/2006 (UL L 353, 31.12.2008, str. 1).
EC No: N/A
ES: ni relevantno
CAS No: 94361-06-5
Št.
Cyproconazole has two diastereomers.
CAS: 94361-06-5
Diastereomer A: enantiomeric pair, where the 2-hydroxy group and the 3-hydrogen are located on the same side (2S, 3S and 2R, 3R).
Ciprokonazol ima dva diastereomera.
Diastereomer B: enantiomeric pair, where the 2-hydroxy group and 3-hydrogen are located on opposite sides (2R, 3S and 2S, 3R).
Diastereomer A: par enantiomerov, pri čemer se 2-hidroksi skupina in vodik na mestu 3 nahajata na isti strani (2S, 3S in 2R, 3R).
Technical cyproconazole is ca 1:1 mixture of the two diasteriomers, each of which is exactly a 1:1 mixture of the enantiomers.
Diastereomer B: par enantiomerov, pri čemer se 2-hidroksi skupina in vodik na mestu 3 nahajata na nasprotnih straneh (2S, 3S in 2S, 3R).
Cyproconazole has two diastereomers
Tehnični ciprokonazol je mešanica dveh diastereomerov v razmerju približno 1:1, od katerih je vsak mešanica enantiomerov točno v razmerju 1:1.
(Diastereoisomer A: 430-500 g/kg,
Ciprokonazol ima dva diastereomera.
Diastereoisomer B: 470-550 g/kg).
(Diastereomer A: 430–500 g/kg,
1 November 2015
Diastereomer B: 470–550 g/kg,
31 October 2020
1. november 2015
Cyproconazole is considered a candidate for substitution in accordance with Article 10(1)(a) and (d) of Regulation (EU) No 528/2012.
31. oktober 2020
The product assessment shall pay particular attention to the exposures, the risks and the efficacy linked to any uses covered by an application for authorisation, but not addressed in the Union level risk assessment of the active substance.
Ciprokonazol se obravnava kot snov za zamenjavo v skladu s členom 10(1)(a) in (d) Uredbe (EU) št. 528/2012.
Authorisations are subject to the following conditions:
Pri oceni proizvoda je treba posebno pozornost nameniti vidikom izpostavljenosti, tveganja in učinkovitosti, povezanim s katero koli uporabo, zajeto v vlogi za izdajo dovoljenja, ki pa ni bila obravnavana v oceni tveganja aktivne snovi na ravni Unije.
For industrial users, safe operational procedures and appropriate organizational measures shall be established.
Dovoljenja se izdajo pod naslednjimi pogoji.
Where exposure cannot be reduced to an acceptable level by other means, products shall be used with appropriate personal protective equipment.
Za industrijske uporabnike se vzpostavijo postopki varnega ravnanja in primerni organizacijski ukrepi.
Products shall not be authorised for industrial use by double vacuum impregnation, unless data is submitted to demonstrate that the product will not present unacceptable risks, if necessary by the application of appropriate mitigation measures.
Če izpostavljenosti ni mogoče zmanjšati na sprejemljivo raven z drugimi načini, se proizvodi uporabljajo z ustrezno osebno zaščitno opremo.
Appropriate risk mitigation measures shall be taken to protect the soil and aquatic compartments.
Dovoljenje za proizvode se ne sme izdati za industrijsko uporabo z dvojno vakuumsko impregnacijo, razen če so predloženi podatki, ki dokažejo, da proizvod ne predstavlja nesprejemljivega tveganja, po potrebi z ustreznimi ukrepi za zmanjševanje tveganja.
In particular:
Sprejmejo se ustrezni ukrepi za zmanjšanje tveganja za varovanje tal in vodnih ekosistemov.
a.
Zlasti:
b.
dovoljenje za proizvode se ne sme izdati za industrijsko obdelavo lesa, ki bo izpostavljen vremenskim vplivom, ali za obdelavo lesa, namenjenega za konstrukcije na prostem, razen če se predložijo podatki, ki dokazujejo, da proizvod ne predstavlja nesprejemljivega tveganja, po potrebi z ustreznimi ukrepi za zmanjševanje tveganja.
Products shall not be authorised for industrial treatment of wood that will be exposed to weathering, or for treatment of wood that will be used for outdoor constructions, unless data is submitted to demonstrate that the product will not present unacceptable risks, if necessary by the application of appropriate mitigation measures.
Čistost, navedena v tem stolpcu, je bila minimalna stopnja čistosti aktivne snovi, uporabljene za oceno v skladu s členom 8 Uredbe (EU) št. 528/2012.
The purity indicated in this column was the minimum degree of purity of the active substance used for the evaluation made in accordance with Article 8 of Regulation (EU) No 528/2012.
Čistost aktivne snovi v proizvodu, danem na trg, je lahko enaka ali drugačna, če je dokazano tehnično enakovredna aktivni snovi iz ocene.
Commission Implementing Regulation (EU) No 439/2014
Izvedbena uredba Komisije (EU) št. 439/2014
amending Regulation (EC) No 250/2009 implementing Regulation (EC) No 295/2008 of the European Parliament and of the Council concerning structural business statistics, as regards the definitions of characteristics and the technical format for the transmission of data
o spremembi Uredbe (ES) št. 250/2009 o izvajanju Uredbe (ES) št. 295/2008 Evropskega parlamenta in Sveta o strukturni statistiki podjetij glede opredelitev karakteristik in tehničnega formata za prenos podatkov
Having regard to Regulation (EC) No 295/2008 of the European Parliament and of the Council of 11 March 2008 concerning structural business statistics [1], and in particular Article 11(1)(a) and (c) thereof,
ob upoštevanju Uredbe (ES) št. 295/2008 Evropskega parlamenta in Sveta z dne 11. marca 2008 o strukturni statistiki podjetij [1] in zlasti člena 11(1)(a) in (c) Uredbe,
Regulation (EC) No 295/2008 of the European Parliament and the Council established a common framework for the collection, transmission and evaluation of European statistics on the structure, activity, competitiveness and performance of businesses in the Union.
Uredba (ES) št. 295/2008 je vzpostavila skupni okvir za zbiranje, pošiljanje in ocenjevanje evropskih statističnih podatkov o strukturi, dejavnosti, konkurenčnosti ter rezultatih podjetij v Uniji.
Commission Regulation (EC) No 250/2009 [2] established the definitions of characteristics and the technical format for the transmission of data.
Uredba Komisije (ES) št. 250/2009 [2] je vzpostavila opredelitve karakteristik in tehnični format za prenos podatkov.
It is necessary to specify definitions for the characteristics of the demography of enterprises with at least one employee to respond to the need for increased international comparability of results, especially for statistics on entrepreneurship.
Zaradi potrebe po večji mednarodni primerljivosti rezultatov, zlasti za statistiko o podjetništvu, je treba določiti opredelitve za karakteristike demografije podjetij z vsaj enim zaposlenim.
These definitions should be added in Annex I to Regulation (EC) No 250/2009.
Te opredelitve bi bilo treba dodati v Prilogo I k Uredbi (ES) št. 250/2009.
The technical format for the transmission of data as set out in Annex II to Regulation (EC) No 250/2009, including the list of data set identifiers, the series and the list of variables should therefore be updated accordingly.
Tehnični format za prenos podatkov, kot je določeno v Prilogi II k Uredbi (ES) št. 250/2009, vključno z oznakami podatkovnih nizov, serijo in seznamom spremenljivk, bi bilo zato treba ustrezno posodobiti.
Annexes I and II to Regulation (EC) No 250/2009 are amended in accordance with the Annex to this Regulation.
Prilogi I in II k Uredbi (ES) št. 250/2009 se spremenita v skladu s Prilogo k tej uredbi.
OJ L 97, 9.4.2008, p.
UL L 97, 9.4.2008, str.
Commission Regulation (EC) No 250/2009 of 11 March 2009 implementing Regulation (EC) No 295/2008 of the European Parliament and of the Council as regards the definitions of characteristics, the technical format for the transmission of data, the double reporting requirements for NACE Rev.1.1 and NACE Rev.2 and derogations to be granted for structural business statistics (OJ L 86, 31.3.2009, p.
Uredba Komisije (ES) št. 250/2009 z dne 11. marca 2009 o izvajanju Uredbe (ES) št. 295/2008 Evropskega parlamenta in Sveta glede opredelitev karakteristik, tehničnega formata za prenos podatkov, dvojnih zahtev za poročanje za NACE Rev.
1).
1.1 in NACE Rev.
ANNEX
2 ter dovoljenih odstopanjih za strukturno statistiko podjetij (UL L 86, 31.3.2009, str. 1).
Annexes I and II to Regulation (EC) No 250/2009 are amended as follows:
PRILOGA
Annex I is amended as follows:
Prilogi I in II k Uredbi (ES) št. 250/2009 se spremenita:
the following Codes are inserted before Code 11 11 0:
Priloga I se spremeni:
‘Code
naslednje oznake se vstavijo pred oznako 11 11 0:
Name
„Oznaka
Population of active enterprises having at least one employee in t
Ime
Annex
Populacija aktivnih podjetij, ki imajo vsaj enega zaposlenega v letu t
Definition:
Priloga
A count of market enterprises that had at least one employee at any time during a given reference period t.
Opredelitev:
Code
Število tržnih podjetij, ki so imela vsaj enega zaposlenega kadar koli med obdobjem opazovanja t.
Number of active enterprises that have the first employee in t
Oznaka
A count of market enterprises that had the first employee at any time during a given reference period t.
Število aktivnih podjetij s prvim zaposlenim v letu t
This can concern births of enterprises as defined in 11 92 0, but also enterprises as defined in 11 91 0 if the enterprises have already been active in previous reference periods, but did not have any employee in two previous reference periods.
Število tržnih podjetij, ki so imela prvega zaposlenega kadar koli med obdobjem opazovanja t.
Number of enterprises having no employees anymore from any point in time in t
To se lahko nanaša na novonastala podjetja, kakor je opredeljeno v 11 92 0, pa tudi na podjetja, kakor so opredeljena v 11 91 0, če so bila podjetja že dejavna v preteklih referenčnih obdobjih, vendar niso imela zaposlenih v prejšnjih dveh obdobjih opazovanja.
A count of market enterprises that have no employees anymore from any point in time in a given reference period t and that had at least one employee at an earlier point in time in a given reference period t.
Število podjetij, ki od katerega koli trenutka v letu t nimajo več zaposlenih
This can concern deaths of enterprises as defined in 11 93 0, with at least one employee, but also enterprises as defined in 11 01 0 if the enterprises still remain active, but have no employees any more from any point in time in a given reference period t and the two following reference periods: t + 1 and t + 2.
Število podjetij, ki od katerega koli trenutka v letu t nimajo več zaposlenih v obdobju opazovanja t in so imela vsaj enega zaposlenega kdaj prej v obdobju opazovanja t.
The same applies if the contract of employment of the last employee ends in t on 31 December.
To se lahko nanaša na prenehanje poslovanja podjetij, kakor je opredeljeno v 11 93 0, z vsaj enim zaposlenim, vendar tudi na podjetja, kakor so opredeljena v 11 01 0, če podjetja ostanejo aktivna, vendar nimajo več zaposlenih od katerega koli trenutka v obdobju opazovanja t in dveh naslednjih obdobjih opazovanja: t + 1 in t + 2.
Number of enterprises that had the first employee at any point in time in t – 1 and that had also at least one employee at any point in time in t
Enako velja, če se pogodba o zaposlitvi zadnjega zaposlenega konča v letu t 31. decembra.
Number of enterprises that had the first employee at any point in time in t – 2 and that had also at least one employee at any point in time in t
Število podjetij, ki so imela prvega zaposlenega v katerem koli trenutku v letu t – 1 in so imela tudi vsaj enega zaposlenega v katerem koli trenutku v letu t
Number of enterprises that had the first employee at any point in time in t – 3 and that had also at least one employee at any point in time in t
Število podjetij, ki so imela prvega zaposlenega v katerem koli trenutku v letu t – 2 in so imela tudi vsaj enega zaposlenega v katerem koli trenutku v letu t
Number of enterprises that had the first employee at any point in time in t – 4 and that had also at least one employee at any point in time in t
Število podjetij, ki so imela prvega zaposlenega v katerem koli trenutku v letu t – 3 in so imela tudi vsaj enega zaposlenega v katerem koli trenutku v letu t
Name:
Število podjetij, ki so imela prvega zaposlenega v katerem koli trenutku v letu t – 4 in so imela tudi vsaj enega zaposlenega v katerem koli trenutku v letu t
Number of enterprises that had the first employee at any point in time in t – 5 and that had also at least one employee at any point in time in t
Ime
A count of market enterprises having had at least one employee at any point in time in every year from the year of having the first employee (t – 1 to t – 5) until a given reference period t.
Število podjetij, ki so imela prvega zaposlenega v katerem koli trenutku v letu t – 5 in so imela tudi vsaj enega zaposlenega v katerem koli trenutku v letu t
The population of enterprises that have the first employee in t is defined as in characteristics 11 02 0.
Število tržnih podjetij, ki so imela vsaj enega zaposlenega v katerem koli trenutku v vsakem letu od leta, ko so imela prvega zaposlenega (t – 1 do t – 5) do obdobja opazovanja t.
An enterprise is also considered to have survived if the linked legal unit(s) have ceased to be active, but their activity has been taken over by a new legal unit set up specifically to take over the factors of production of that enterprise (= survival by take-over).’;
Populacija podjetij, ki imajo prvega zaposlenega v letu t, je opredeljena v skladu s karakteristiko 11 02 0.
the following Code is inserted before Code 12 11 0:
Prav tako se obravnava, da je podjetje preživelo, če so povezane pravne enote prenehale opravljati dejavnost in je to dejavnost prevzela nova pravna enota, ki je bila ustanovljena posebej za prevzem proizvodnih dejavnikov tega podjetja (= preživetje s prevzemom).“
Number of high growth enterprises measured in employment in t
naslednja oznaka se vstavi pred oznako 12 11 0:
A count of market enterprises, having at least 10 employees in t – 3, with average annualised growth in number of employees greater than 10 % per annum, over a three year period (t – 3 to t).
Število podjetij z visoko rastjo, izmerjeno v zaposlovanju v letu t
It does not include enterprises, as defined in 11 92 0, in t – 3.’;
Število tržnih podjetij z vsaj 10 zaposlenimi v letu t – 3 s povprečno letno rastjo števila zaposlenih več kot 10 % na leto v obdobju treh let (t – 3 do t).
the following Codes are inserted before Code 16 11 0:
Ne vključuje podjetij, kakor so opredeljena v 11 92 0, v letu t – 3.“